Brief: Zynerba Pharmaceuticals Announces Publication Of Results Of Phase 2 Study Of Zygel In Children And Adolescents With Developmental And Epileptic Encephalopathies
07/09/2021 12:21
Sept 7 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS ANNOUNCES PUBLICATION OF RESULTS
OF
PHASE 2 BELIEVE OPEN-LABEL STUDY OF ZYGEL™ IN CHILDREN AND
ADOLESCENTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
(DEE) IN JAMA NETWORK OPEN
Source text for Eikon: ID:nGNX3RTqmW
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary